| 000 | 01666 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250517225712.0 | ||
| 264 | 0 | _c20191211 | |
| 008 | 201912s 0 0 eng d | ||
| 022 | _a1555-905X | ||
| 024 | 7 |
_a10.2215/CJN.13811217 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aShin, Jung-Im | |
| 245 | 0 | 0 |
_aRisks and Benefits of Direct Oral Anticoagulants across the Spectrum of GFR among Incident and Prevalent Patients with Atrial Fibrillation. _h[electronic resource] |
| 260 |
_bClinical journal of the American Society of Nephrology : CJASN _c08 2018 |
||
| 300 |
_a1144-1152 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnticoagulants _xadministration & dosage |
| 650 | 0 | 4 |
_aAtrial Fibrillation _xcomplications |
| 650 | 0 | 4 |
_aBrain Ischemia _xetiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGlomerular Filtration Rate |
| 650 | 0 | 4 |
_aHemorrhage _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPrevalence |
| 650 | 0 | 4 |
_aRenal Insufficiency, Chronic _xcomplications |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 |
_aStroke _xetiology |
| 650 | 0 | 4 |
_aWarfarin _xadministration & dosage |
| 700 | 1 | _aSecora, Alex | |
| 700 | 1 | _aAlexander, G Caleb | |
| 700 | 1 | _aInker, Lesley A | |
| 700 | 1 | _aCoresh, Josef | |
| 700 | 1 | _aChang, Alex R | |
| 700 | 1 | _aGrams, Morgan E | |
| 773 | 0 |
_tClinical journal of the American Society of Nephrology : CJASN _gvol. 13 _gno. 8 _gp. 1144-1152 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2215/CJN.13811217 _zAvailable from publisher's website |
| 999 |
_c28626585 _d28626585 |
||